Home› India› Ministry of Finance› In exercise of the powers conferred by subclause (b) of clau...
Date: 2021-03-23 Category: Extra Ordinary State: Union Government Country: India

In exercise of the powers conferred by subclause (b) of clause xi of section 2 of the Narcotic Drugs and Psychotropic Substances Act

Issued by Ministry of Finance · Department of Revenue

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Okay, I will analyze the provided policy text and generate the report as requested. **Report on Amendments to Regulations Concerning Narcotic Drugs and Psychotropic Substances** **1. Executive Summary:** This report analyzes two notifications issued by the Ministry of Finance, Department of Revenue, Government of India, both dated March 23, 2021. The first notification (S.O. 1274(E)) declares several fentanyl derivatives as manufactured drugs under the Narcotic Drugs and Psychotropic Substances Act, 1985. The second notification (S.O. 1275(E)) amends a prior notification (S.O. 1055(E) dated October 19, 2001) by adding several new substances to the list of psychotropic substances in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985, and also amends another notification specifying the Small Quantity and Commercial Quantity for various substances.. These actions appear aimed at controlling the proliferation and abuse of these substances by classifying them for regulatory purposes and defining quantity thresholds. **2. Introduction:** This report provides an overview of two notifications issued by the Ministry of Finance, Department of Revenue, Government of India, regarding amendments to regulations concerning narcotic drugs and psychotropic substances. The analysis is based solely on the content of the provided notifications. **3. Policy Overview:** * These are amendments to existing policies. * **Core Objectives (as inferred from the text):** The core objectives appear to be: * To expand the list of controlled substances under the Narcotic Drugs and Psychotropic Substances Act, 1985, to include newly identified fentanyl derivatives and other psychotropic substances. * To set quantity limits for these substances for regulatory and enforcement purposes. * To keep the list of controlled substances aligned with international conventions. **4. Background and Rationale:** The amendment adding fentanyl derivatives as manufactured drugs likely responds to the emergence and increasing abuse of these substances. Fentanyl derivatives are known for their high potency and associated risks of overdose and death. The second notification suggests that the government has become aware of new psychotropic substances, whether natural or synthetic, and their potential for abuse. The reference to the United Nations Convention on Psychotropic Substances 1971 suggests an effort to align domestic regulations with international standards and address substances of international concern. **5. Key Provisions / Changes:** This section details the changes introduced by the provided amendment text (S.O. 1274(E) and S.O. 1275(E)). * **S.O. 1274(E):** This notification declares the following substances and their salts and preparations as manufactured drugs: * Crotonylfentanyl * Valerylfentanyl * Parafluorobutyrylfentanyl * OrthoFluorofentanyl * Methoxyacetyl fentanyl * Cyclopropylfentanyl This change brings these substances under the regulatory control of the Narcotic Drugs and Psychotropic Substances Act, 1985, making their production, sale, possession, and use subject to legal restrictions. * **S.O. 1275(E):** This notification amends the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985, by inserting the following substances: * AB-FUBINACA * 5F-AMB-PINACA * 5F-MDMB-PICA * 4F-MDMB-BINACA * 4-CMC (4-chloromethcathinone, clephedrone) * N-ethylhexedrone * alpha-PHP * Flualprazolam * Etizolam * DOC (4-Chloro-2,5-dimethoxyamphetamine) * ADB-FUBINACA * FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) * CUMYL-4CN-BINACA * ADB-CHMINACA (MAB-CHMINACA) * N-ethylnorpentylone This notification replaces entries for previously listed substances and provides revised "Small Quantity" and "Commercial Quantity" limits in grams (gm) and kilograms (kg). The table provides details on the Chemical name, Small Quantity and Commercial Quantity for each substance listed from 238ZI to 238ZZO. The effect of this change is to subject these new substances to the controls outlined in the Narcotic Drugs and Psychotropic Substances Act, 1985. It also changes the previous quantities defined for regulatory purposes. **6. Target Audience and Stakeholders:** The target audience and stakeholders directly affected by these changes include: * Pharmaceutical manufacturers and distributors * Chemical manufacturers and suppliers * Research institutions and laboratories * Law enforcement agencies * Healthcare professionals * Individuals who use or are involved in the trafficking of these substances. **7. Implementation Aspects (Inferred):** * **Responsible agency/bodies:** The Ministry of Finance, Department of Revenue, is the responsible body for issuing these notifications. Law enforcement agencies are responsible for enforcing the provisions of the Narcotic Drugs and Psychotropic Substances Act, 1985. * **Timelines or procedures:** The notifications are effective from the date of their publication in the Gazette of India (March 23, 2021). Specific procedures for licensing, import/export, and other regulatory requirements are likely outlined in the Narcotic Drugs and Psychotropic Substances Act, 1985, and related rules. * **Implementation Aspects Specific to Amendments:** Enforcement agencies will need to update their lists of controlled substances and be trained to identify and handle these newly listed substances. The industries dealing with chemicals will need to ensure they are not dealing with newly prohibited substances without proper licensing. **8. Expected Outcomes / Impact of Changes:** * **S.O. 1274(E):** The intended outcome is to reduce the availability and abuse of fentanyl derivatives by classifying them as manufactured drugs. * **S.O. 1275(E):** The expected outcomes of these changes are to: * Reduce the availability and abuse of the newly listed psychotropic substances. * Facilitate law enforcement efforts to control the trafficking and distribution of these substances. * Protect public health by preventing the harmful effects associated with the use of these substances. * Align domestic regulations with international standards. * Provide clearer guidelines for regulatory oversight, prosecution, and penalties. **9. Conclusion:** The notifications issued by the Ministry of Finance, Department of Revenue, represent a proactive effort to address the evolving challenges posed by new psychoactive substances. By expanding the list of controlled substances and updating quantity limits, the government aims to strengthen its regulatory framework and protect public health. These changes have significant implications for various stakeholders, including pharmaceutical companies, research institutions, law enforcement agencies, and individuals involved in the use or trafficking of these substances. The specific amendments concerning quantities aim for better control in tracking narcotics and ensure prosecution reflects the severity of offense.

Key Entities Referenced

Ministry of Finance: The Indian government ministry responsible for financial matters. Department of Revenue: A department within the Ministry of Finance. New Delhi: Capital of India, location where the notification was issued. Narcotic Drugs and Psychotropic Substances Act, 1985: An act of the Indian Parliament to consolidate and amend the laws relating to narcotic drugs, to make stringent provisions for the control and regulation of operations relating to narcotic drugs and psychotropic substances. Central Government: The federal government of India. United Nations Convention on Psychotropic Substances 1971: An international treaty designed to control psychotropic substances such as amphetamines, barbiturates, hallucinogens, and tranquilizers. Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985: A list of psychotropic substances regulated under the Narcotic Drugs and Psychotropic Substances Act, 1985. AB-FUBINACA: A synthetic cannabinoid. 5F-AMB-PINACA: A synthetic cannabinoid. 5F-MDMB-PICA: A synthetic cannabinoid. 4F-MDMB-BINACA: A synthetic cannabinoid. 4-CMC: A synthetic cathinone. N-ethylhexedrone: A stimulant drug of the cathinone class. alpha-PHP: A synthetic stimulant drug of the cathinone class. flualprazolam: A synthetic depressant drug of the benzodiazepine class. Etizolam: A synthetic depressant drug of the thienodiazepine class. DOC: A psychedelic drug of the amphetamine class. ADB-FUBINACA: A synthetic cannabinoid. FUB-AMB: A synthetic cannabinoid. CUMYL-4CN-BINACA: A synthetic cannabinoid. ADB-CHMINACA: A synthetic cannabinoid. N-ethylnorpentylone: A synthetic cathinone. Carfentanil: An opioid analgesic. Ocfentanil: An opioid analgesic. Furanylfentanyl: A synthetic opioid. Acryloylfentanyl: A synthetic opioid. Tetrahydrofuranylfentanyl: A synthetic opioid. UR-144: A synthetic cannabinoid. 5F-PB-22: A synthetic cannabinoid. 4-Fluoroamphetamine: A stimulant drug. 5F-AMB: A synthetic cannabinoid. 4F-MDMB-BINACA: A synthetic cannabinoid. Crotonylfentanyl: A synthetic opioid. Valerylfentanyl: A synthetic opioid. Parafluorobutyrylfentanyl: A synthetic opioid. Ortho-Fluorofentanyl: A synthetic opioid. Methoxyacetyl fentanyl: A synthetic opioid. Cyclopropylfentanyl: A synthetic opioid.
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 xxxGIDHxxx सी.जी.-डी.एxलx.x-GअID.-E2xx3x0 32021-226041 CG-DL-E-23032021-226041 असाधारण EXTRAORDINARY भाग II—खण्ड 3—उप-खण्ड (ii) PART II—Section 3—Sub-section (ii) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 1181] नई ददल्ली, मगं लिार, माच च23, 2021/च्ै 2, 1943 No. 1181] NEW DELHI, TUESDAY, MARCH 23, 2021/CHAITRA 2, 1943 जित्त म्ं ालय (रािस्ट्ि जिभाग अजधसचू ना नई ददल् ली, 23 माचच, 2021 का.आ. 1274(अ .—निीली दिाओं और स्ट् िापक पदाथच अजधजनयम, 1985 (1985 का 61 की धारा 2 के उपजनयम (xi के उपखंड (ख में प्रदत् त िजतियय का प्रयगग करते ुए, एतद्दिारा, केन्‍द र सरकार जनज नजलजखत तत्ि , नमक और उससे बनी सामग्री कग जनर्ममत दिा घगजित करती ह,ै यथा:- (i) क्रगटगनीफेलेंटेनल: (2 ई -एन-दफनाइल-एन- [1- (2-फेजनलथाइल जपपेररजडन-4-यल] बट 2-एनामाइड; (ii) िेलेरीफेलेंटेनल: एन-फेजनल-एन- [1- (2-फेजनलथाइल जपपेररजडन-4-यल] पेंटानैमाइड; (iii) पैराफ्लगरगबूरीफ्लगरेंटैनल: एन- (4-फ्लगरगदफनाइल -एन- [1- (2-फेजनलथाइल जपपेररजडन-4-यल] ब्यूटामाइड; (iv) ऑथो-फ्लगरगफेंटेनल: एन- (2-फ्लगरगदफनाइल -एन- [1- (2-फेजनलथाइल जपपेररजडन-4-िाईएल] प्रगपेनामाइड; (v) मेथगक्सीजसरटल फेंटेनल: 2-मेथॉक्सी-एन-फेजनल-एन- [1- (2-फेजनलथाइल जपपेररजडन-4-यल] एजसटामाइड; (vi) साइक्लगप्रगपाइलफेंटेनल: एन-फेजनल-एन- [1- (2-फेजनलथाइल जपपेररजडन-4-यल] साइक्लगप्रगपेन काबोक्सामाइड। [फा. सं. एन-13/01/2019-एनसी-II] ददनेि बौध्द, जनदेिक 1730 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] MINISTRY OF FINANCE (Department of Revenue) NOTIFICATION New Delhi, the 23rd March, 2021 S.O. 1274(E).—In exercise of the powers conferred by sub-clause (b) of clause (xi) of section 2 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby declares the following substances, salts and preparations thereof to be manufactured drugs, namely: - (i) Crotonylfentanyl: (2E)-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]but-2-enamide; (ii) Valerylfentanyl: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide; (iii) Parafluorobutyrylfentanyl: N-(4-fluorophenyl)-N-[1-(2-phenylethyl) piperidin-4-yl] butanamide; (iv) Ortho-Fluorofentanyl: N-(2-fluorophenyl)-N-[1-(2-phenylethyl) piperidin-4-yl] propanamide; (v) Methoxyacetyl fentanyl: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl] acetamide; (vi) Cyclopropylfentanyl: N-Phenyl-N-[1-(2-phenylethyl) piperidin-4-yl] cyclopropane carboxamide. [F. No. N-13/01/2019-NC-II] DINESH BOUDDH, Director अजधसचू ना नई ददल् ली, 23 माचच, 2021 का.आ. 1275(अ .—िहां दक केन्‍द र सरकार जन न जलजखत तत्ि (प्राककजतक या जस न्‍द थेरटक या प्राककजतक माल या कगई भी नमक या ऐसे तत्ि से बने पदाथच या माल के दयोप पयगग का ेे् और प्रभाि और प्रककजत के संबंध में और यूनाइटेड नेिन्‍द स कनिेंिन ऑन साइकगरॉजपक सब् सटॉजन्‍द सस, 1971 में ऐसे तत्ि के संबंध में दकए गए पररितचन और बदलाि कग िाजमल दकया गया ह,ै उपलब्ध सूचना और सा्य के आधार पर संतप्‍ट हगत े ुए दक निीली दिाओं और स्ट् िापक पदाथ च अजधजनयम, 1985 (1985 का 61 (एतत्पश् चात उक्त अजधजनयम से संदर्मभत दकया गया ह ै , की अनपसूची में जिजनर्दद्‍ ट निीले पदाथों की सूची में जन न जलजखत पदाथों या प्राककजतक माल या नमक या ऐसे तत्ि से बने पदाथच या माल कग िग ा िाना आिश् यक ह;ै अत: अब उक्त अजधजनयम की धारा 3 में प्रदत् त िजतियय का प्रयगग करते ुए, केन्‍द र सरकार, एतद्द्वारा, उक्त अजधजनयम की अनपसूची में जिजनर्दद्‍ ट स्ट् िापक पदाथों की सूची में और आगे जन न जलजखत संिगधन करती ह,ै यथा :- उक्त अजधजनयम म,ें अनपसूची म,ें क्रम सं. 110 ZE. और उससे संबंजधत प्रजिजिय के बाद जन न जलजखत क्रम.संख्य ाओं और प्रजिजिय कग अंत: स्ट् थाजपत दकया गया ह,ै यथा :- क्र.सं. अन्‍द तराच्‍र ीय नान- अन्‍द य नान-प्रगप्रीटरी नेमस रसायजनक नेमस प्रगप्रीटरी नेमस “110ZF एबी-फ्यूबीनाका एन-[(2एस)-1-अमीनग-3-मैथाइल-1-ओक्स ाबूटन-2-]- 1-[(4फ्लपओरगफेनाइल) मैथाइल] इंडािेडगल-3- कॉरबगएक् साजमड 110ZG 5 एफ-एएमबी- मैथाइल 2-({[1-(5-फ्लओप रगफेनटाइल)-1एच- जपनाका(5एफ-एएमबी, इंडािेडगल 3यल] कारबगजनल} अमीनग)-3- 5एफ-एमएमबी-जपनाका) मैथेलबूटपनगएट 110ZH 5 एफ -एमडीएमबी-जपका मैथाइल(एस)-2-(1-(5- फ्लपओरगफेनटाइल)-1एच- (5 एफ - एमडीएमबी - इंडगल-3- कॉरबगएक् साजमड)-3,3- जडमैथले बूटपनगएट 2201)[भाग II—खण् ड 3(ii)] भारत का रािप् : असाधारण 3 110ZI 4एफ- एमडीएमबी - मैथाइल (एस)-2-(1-(4-फ्लपओरगब् यूटाइल)-1एच- जबनाका इंडािेडगल -3-कॉरबगएक्स ाजमड)-3, 3- जडमैथेलबूटपनगएट 110ZJ 4-सीएमसी (4- सेलीदफडरगन 1-(4-क्ल गरगदफनाइल)-2-(मैथाइलजमनग)-1- परगपेन (क्ल गरगमथै कैजथजहनगन 110ZK एन-एथायलहक्े स ीडरगन 2-(इथाइलजमनग)-1-दफ नाइल-हक्े ि ानगन 110ZL अल् फा-पीएचपी (आर एस)-1- दफ नाइल -2-(पयासेजलडीन-1-यल) हग्े िन-1-िन 110ZM फयूलपैरािगलम 8-क्ल गरग-6-(2-फ्लगरग- दफ नाइल)-1-मैथाइल-4एच बेनिेडग[एफ][1,2,4]टररयािेडगलग[4,3- ए][1,4]जडयायइफाइम 110ZN इटीिेडगहलम 4-(2- क्ल गरगदफनाइल)-2-इथाइल-9- मैथाइल - 6एच-जथयेनग[3,2- एफ][1,2,4]टररयािेडगलग[4,3ए][1,4]डीयािेडीपाईन 110ZO डीओसी 4-क्ल गरग-2,5-डीमैथगएग्ि यामफेटामाइन 110ZP एडीबी-फयूबीनाका एन-[(2एस)-1-अमीनग-3,3-डाईमैथाइल-1- ओक्स गब य ूटन-2- यल]-1-[(4- फ्लगरगदफ नाइल) मैथाइल]-1हहडािेडगल-3-कारबगएक् सामाइड 110ZQ एफयूबी-एएमबी, मैथाइल (2एस)-2-({1-[4- फ्लगरगदफ नाइल] मैथाइल एमएमबी फयूबीनाका, -1 हहडािडे गल -3-कॉरबगजनल }अजमनग)-3- एएमबीफयूबीनाका मैथेलबूटपनगएट 110ZR क्य मू ाइल-4सीएनबीनाका 1-(4-साइनगब्य टू ल)-एन-(2दफनाइलपरगपन-2-यल)- 1 हहडािेडगल -3- कारबगएक् सामाइड 110ZS एडीबी-जचमनाका, एन-[(2एस)-1-अजमनग-3,3-डीमैथाइल-1- एमएबी-जचमनाका ओक्स गब् यटू न-2- यल]-1-(साइक् लगहक् साइल मथै ाइल)- 1एच- हहडािेडगल -3- कारबगएक् सामाइड 110ZT एन- 1-(2एच-1,3-बेनयओजडयगओक्स गल-5-यल)-2- इथाइलनगरफेनटाईलगन (इथाइलजमनग)पेंटन-1-िन [फा. सं. एन-13/1/2019-एनसी. II] ददनेि बौध्द, जनदेिक रटप्प णी: निीली दिाओं और स्ट्ि ापक पदाथच अजधजनयम, 1985 (1985 का 61 , की अनपसूची में का.आ. 785(अ , ददनांक 26 अक् टूबर, 1992 के तहत पहली बार संिगधन दकया गया था और इसमें बाद म ें संिगधन का.आ 49(अ , ददनांक 8 िनिरी, 1993, का.आ.39(अ , ददनांक 12 िनिरी, 1996, का.आ.475(अ , ददनांक 11 िून, 2003, सा.का.जन 621(अ , ददनांक 1 अगस्ट् त, 2003, सा.का.जन 1(अ , ददनांक 2 िनिरी, 2004, का.आ. 311 (अ , ददनांक 10 फरिरी, 2011, का.आ.376 (अ , ददनांक 5 फरिरी, 2015, का.आ. 2374 (अ , ददनांक 12 िपलाई, 2016, का.आ.No. 1383 (अ , ददनांक 2 मई, 2017, का.आ. 821(अ , ददनांक 27 फरिरी, 2018, का.आ.1761(अ , ददनांक 26 अप्रैल, 2018, का.आ. 3448(अ ददनांक 13 िपलाई, 2018 और का.आ. 1352(अ ददनांक 13 माच,च 2019 के अन्‍दत गचत दकया गया ह।ै4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] NOTIFICATION New Delhi, the 23rd March, 2021 S.O. 1275(E).—Whereas the Central Government is satisfied, on the basis of information and evidence which has become available to it, with respect to the nature and effect of and the scope for abuse of the following substances (natural or synthetic) or natural material or any salt or preparation of such substances or materials, and the modification with respect to such substances and the changes that have been incorporated in the United Nations Convention on Psychotropic Substances 1971, that it is necessary to add the following substances or natural materials or salts or preparation of such substances or materials in the list of psychotropic substances specified in the Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) (hereinafter referred to as the said Act); Now, therefore, in exercise of the powers conferred by section 3 of the said Act, the Central Government hereby makes the following further amendments in the list of psychotropic substances specified in the Schedule to the said Act, namely: - In the said Act, in the Schedule, after serial number 110 ZE and the entries relating thereto, the following serial numbers and entries shall be inserted, namely: - SI. No. International Other Chemical name non-proprietary names non-proprietary names “110ZF AB-FUBINACA N-[(2S)-1-amino-3-methyl-1- oxobutan-2-yl]-1- [(4-fluorophenyl) methyl] indazole-3- carboxamide 110ZG 5F-AMB-PINACA (5F-AMB, Methyl 2-({[1-(5-fluoropentyl)-1H- 5F-MMB-PINACA) indazol3yl] carbonyl} amino)-3- methylbutanoate 110ZH 5F-MDMB-PICA (5F-MDMB- Methyl(S)-2-(1-(5-fluoropentyl)- 2201) 1H-indole-3- carboxamido)-3,3- dimethylbutanoate 110ZI 4F-MDMB-BINACA Methyl(S)-2-(1-(4-fluorobutyl)-1H- indazole-3- carboxamido)-3,3- dimethylbutanoate 110ZJ 4-CMC (4- clephedrone 1-(4-chlorophenyl)-2- chloromethcathinone) (methylamino)-1- propanone 110ZK N-ethylhexedrone 2-(Ethylamino)-1-phenyl-1- hexanone 110ZL alpha-PHP (RS)-1-Phenyl-2-(pyrrolidine-1- yl)hexan-1-one 110ZM flualprazolam 8-Chloro-6-(2-fluoro-phenyl)-1- methyl- 4hbenzo[f][1,2,4]triazolo[4,3- a][1,4]diazepime 110ZN Etizolam 4-(2-Chlorophenyl)-2-ethyl-9- methyl-6H-thieno[3,2- f][1,2,4]triazolo[4,3a][1,4]diazepine 110ZO DOC 4-Chloro-2,5- dimethoxyamfetamine 110ZP ADB-FUBINACA N-[(2S)-1-amino-3,3-dimethyl-1- oxobutan-2- yl]-1-[(4- fluorophenyl)methyl]-1Hindazole- 3-carboxamide[भाग II—खण् ड 3(ii)] भारत का रािप् : असाधारण 5 110ZQ FUB-AMB, Methyl(2S)-2-({1-[4- MMBFUBINACA, fluorophenyl]methyl-1Hindazole-3- AMBFUBINACA carbonyl }amino)-3- methylbutanoate 110ZR CUMYL-4CNBINACA 1-(4-cyanobutyl)-N-(2- phenylpropan-2-yl)-1Hindazole-3- carboxamide 110ZS ADB-CHMINACA, MAB- N-[(2S)-1-amino-3,3-dimethyl-1- CHMINACA oxobutan-2- yl]-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide 110ZT N-ethylnorpentylone 1-(2H-1,3-benzodioxol-5-yl)-2- (ethylamino)pentan-1-one”. [F. No. N-13/1/2019-NC. II] DINESH BOUDDH, Director Note: The Schedule to the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985) was first amended vide number S.O. 785(E), dated the 26th October, 1992 and subsequently amended vide numbers S.O. 49(E), dated the 8th January, 1993, S.O. 39(E), dated the 12th January, 1996, S.O. 475(E), dated the 11th June, 2003, G.S.R. 621(E), dated the 1st August, 2003, G.S.R. 1(E), dated the 2nd January, 2004, S. O. 311 (E), dated the 10th February, 2011, S. O. 376 (E), dated the 5th February, 2015, S. O. No. 2374 (E), dated the 12th July, 2016, S.O. No. 1383 (E), dated the 2nd May, 2017, S.O. 821(E), dated the 27th February, 2018, S.O. 1761(E), dated the 26th April, 2018, S.O. 3448(E), dated the 13th July, 2018 and S.O. 1352(E), dated the 13th March, 2019. अजधसचू ना नई ददल् ली, 23 माचच, 2021 का.आ. 1276(अ .—निीली दिाओं और स्ट् िापक पदाथच अजधजनयम, 1985 (1985 का 61 की धारा 2 के उपजनयम (viiक और (xxiiiक में प्रदत् त िजतियय का प्रयगग करते ुए, एतद्दिारा, केन्‍द र सरकार, भारत सरकार, जित् त मं्ालय, रािस्ट् ि जिभाग के का.आ. 1055 (अ), ददनांक 19 अक् टूबर, 2001 जिसे भारत के रािप् , असाधारण, भाग ।।, खण् ड 3, उपखण् ड (ii के तहत प्रकाजित दकया गया था इसमें और आग ेजन न जलजखत संिगधन करती ह,ै यथा:- उक्त अजध सूचना म,ें ताजलका में, क्र.सं. 238 ZI, 238 ZJ, 238 ZK, 238 ZL, 238 ZM, 238 ZN, 238 ZO, 238 ZP, 238ZQ, 238ZR, 238ZS and 238 ZT और उससे संबंजधत प्रजिजिय के बाद जन नजलजखत क्र. संख् याओं और प्रजिजिय कग अंत: प्रजतस्ट् थाजपत दकया िाता ह,ै यथा:- क्र. सं. निीली दिा और स्ट्ि ापक अन्‍द य नॉन रसायजनक नाम लघप मा्ा िाजणजययक पदाथच का नाम प्रॉपराइटरी नेम ( ग्राम में) मा्ा (ग्राम/ (इंटरनेश् नल नॉन दक.ग्रा. में) प्रॉपराइटरी नेम (आइएनएन) “238ZI कारफेंटजनल जमथाइल 1-(2- फेनी जलजथल)-4- 0.00005 0.001 [फेजनल(प्रगपनगइल)यअ ग्राम ग्राम; जमनग]पीपरीडीन-4-कारबॉक्सीलेट 238 ZJ ऑसफेंटलनील एन-(2-फ्लूरगदफनाईल)-2-जमथॉक्सी- 0.00217 0.0434 एन-[1-(2- फेनी जलजथल) पीपरीडीन - ग्राम ग्राम; 4-l] एसीटामाईड6 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 238 ZK फ्यूरेनीलफेंटनील एन-दफनाईल-एन-[1-(2- फेनी जलजथल) 0.02 ग्राम 1 ग्राम; पीपरीडीन -4-िाईएल]फूरन-2- कारबॉक्सामाईड 238 ZL एक्राइलगइलफेंटनील एक्राइलगइलफेंटनील एन-दफनाईल-एन -[1-(2- फेनी जलजथल) 0.0025 0.125 पीपरीडीन -4-िाइएल]प्रगप-2- ग्राम ग्राम; एनामाइड 238ZM 4- 4-FIBF, pFIBF एन-(4-फ्लूरगफेनी)-2-जमथाइल-एन-[1- 0.03 ग्राम 1.5 ग्राम; फ्लूओरगआईसगब्यूररीफेंटानील (2- फेनी जलजथल) पीपरीडीन -4- िाईएल]प्रगपेनामाइड 238 टेराहाईड्रगफ्यूरेनीलफेंटनील THF एन-दफनाईल-एन -[1-(2- फेनी जलथी) 0.005 0.1 ग्राम; ZN पीपरीडीन -4-िाइएल]आक्सगलेन-2- ग्राम कारबॉक्सीमाइड 238 AB- एऩ-[(2एस)-1-अमीनग-3-जमथाइल-1- 0.05 ग्राम 2.5 ग्राम; ZO CHMINACA ऑक्सगब्यूटेन-2-िाइल]-1- (साइक्लगहजे क्सलमेथीl)-1एच- इंडािगल -3- कारबॉक्सीमाइड 238 ZP 5F-ADB (5F- जमथाइल(2एस)-2-{1-(5-फ्लगरगफेंटl)- 0.005 0.25 MDMB- 1एच- इंडािगल -3- काबोजनलजमनग }- ग्राम ग्राम; PINACA) 3,3- डाइजमथाइलब्यूटनेट 238 AB-PINACA एन-[(2एस)-1-अमीनग-3-जमथाइल-1 0.0178 0.892 ZQ ऑक्सगब्यूटेन -2िाईएल]-1-पेंटी 1एच- ग्राम ग्राम; इंडािगल 3-कारबॉक्सीमाइड 238 UR-144 (1-पेंटी-1एच-इंडगल-3- 0.05 ग्राम 2.5 ग्राम; ZR िाईएल)(2,2,3,3- टेराजमथाइलसाइक्लगप्रगपाइल) मैथनगन 238 ZS 5F-PB-22 दिनगजलन-8-िाइएल 1-(5- 0.1 ग्राम 5.0 ग्राम; फ्लपओप्रेंटल)-1एच-इनगडगल-3- काबोजक्सलेट 238 ZT 4-फ्लगरग फेटामी 4-FA 1-(4-फ्लगरगफेजनल) प्रगपेन-2-एमीन 2 ग्राम 50 ग्राम”. 238ZU एबी-फ्यपजबनाका एन-[(2एस)-1-अजमनग-3-जमथाइल-1- 0.025 1.25 ओक्सगब्यूटन -2-यल]-1- [(4- ग्राम ग्राम; फ्लगरगफेनाइल) जमथाइल] इंडािगल-3- कॉरबगअक्साइड 238ZV 5-एएमबी- जमथाइल-2-({[1-(5- फ्लगरगफेनटाइल)- 0.0027 0.135 जपनाका (5एफ- 1एच- इंडािगल 3यल] कॉरबगजनल} ग्राम ग्राम; एएमबी, 5एफ- अजमनग)-3- मैथेलबूटएनगएट एमएमबी- जपनाका) 238ZW 5F-एमडीएमबी- जमथाइल (S)-2-(1-(5- 0.0050 0.25 पीका (5एफ- फ्लगरगफेनटाइल)-1एच-इंडािगल-3- ग्राम ग्राम; एमडीएमबी- कॉरबगएक् साजमडग)-3,3- 2201) डीमैथेलबूटएनगएट 238ZX 4-एमडीएमबी- मैथाइल(एस)-2-(1-(4-फ्लगरगब् यूटल)- 0.0050 0.25 जबनाका 1एच-इंडािगल-3- कॉरबगएक् साजमडग)- ग्राम ग्राम; 3,3-डीमैथेलबूटएनगएट 238ZY 4-सीएमसी(4- सेजलफीड्रगन 1-(4क् लगरगफेनाइल)-2- 5.0 ग्राम 250 ग्राम; क् लगरगमेथकाथीनगन) (मैथाइलअजमनग)-1- परगपेन[भाग II—खण् ड 3(ii)] भारत का रािप् : असाधारण 7 238ZZ एन- 2-(इथाइलाजमनग)-1-फेनाइल-1- 1.0 ग्राम 50 ग्राम; इथीयलहीएक् सड्रग हग्े ि ानगन न 238ZZA अल् फा-पीएचपी (आरएस)-1-फेनाइल-2- 0.1 ग्राम 5.0 ग्राम; (पाइररगजलडाइन-1-यल)हग्े ि न-1-िन 238ZZB फ्यूयलपैराझगलम 8-क् लगरग-6-(2-फ्लगरग-फेनाइल)-1- 0.0125 0.625 मैथाइल-4एच ग्राम ग्राम; बेन्‍द िग[एफ][1,2,4]टररयािगलग[4,3- ए][1,4]जडयािीपेम 238ZZC इटीिगलम 4-(2डीफेनाइल)-2-इथायल-9-मैथाइल- 0.05 ग्राम 2.5 ग्राम; 6एच-जथयानग[3,2- एफ][1,2,4]टररयािगलग[4,3ए][1,4]डी यािीपाइन 238ZZD डीओसी 4-क् लगरग-2,5- 0.15 ग्राम 7.5 ग्राम; डीमैथगओक् सयामफेटामाइन 238ZZE एडीबी-फ्यूबीनाका एन-[(2एस)-1-अजमनग-3,3-डीमैथाइल- 0.01 ग्राम 0.5 ग्राम; 1-ओक् सगब् यूटन2- यल]-1-[(4- फ्लगरगफेनाइल)मैथाइल]-1हहडािगल-3- कॉरबगएक् साजमड 238ZZF एफयूबी-एएमबी, मैथाइल(2S)-2-({1-[4- 0.01 ग्राम 0.5 ग्राम; एमएमबफ्यूजबना फ्लगरगफेनाइल]मैथाइल-1 हहडािगल -3- का, का}अजमनग)-3- मैथाइलब् यूटनगएट एएमबीफयूजबना का 238ZZG कमयल- 1-(4-साइनगब् यूटल)- एन -(2- 0.01 ग्राम 0.5 ग्राम; 4सीएनबीनाका फेनाइलपरगपेन-2-यल)-1हहडािगल-3- कॉरबगएक् साजमड 238ZZH एडीबी-चजमनाका, एन -[(2एस)-1-अजमनग-3,3-डीमैथाइल- 0.005 0.25 एमएबी- 1-ओक् सगब् यूटन-2- यल]-1- ग्राम ग्राम; चजमनाका (साइकलगनेक् सीमैथाइल)-1एच- इंडािगल-3- कॉरबगएक् साजमड 238ZZI एन- 1-(2एच-1,3-बेंिगजडयगिगल-5-यल)-2- 0.1 ग्राम 5 ग्राम; इजथलनगरपैनटाइ (इथाइलअजमन)पेंटन-1-िन लगन 238 करगटगजनयलफेंटनाइल (2ई)-एन-फेनाइल- एन -[1-(2- 0.014 0.28 ZZJ फेनाइली जथल)पेरीडीन-4-यल]बट-2- ग्राम ग्राम; इनामाइड 238 िलेरीलफेंटनाइल एन -फेनाइल- एन -[1-(2- 0.40 ग्राम 8.0 ग्राम; ZZK फेनाइलीजथल)पीपेरीडीन-4- यल]पेंटानमाइड 238 पाराफ्लगरगब् यूटरयलफेंटनाइल एन-(4-फ्लगरगफेनाइल)-एन-[1-(2- 0.005 0.1 ग्राम; ZZL फेनाइली जथइल) पीपरीडीन-4-यल] ग्राम ब् यूटनामाइड 238 ऑथो-फ्लगरगफेंटनाइल एन-(2-फ्लगरगफेनाइल)-ण् न-[1-(2- 0.005 0.1 ग्राम; ZZM फेनाइलीजथल) पीपरीडीन -4-यल] ग्राम परगपेनामाइड8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 238 मैथगक सी 2-मैथगक् सी-एन-फेनाइल-एन-[1-(2- 0.005 0.1 ग्राम; ZZN एसीटायलफेंटनाइल फेनाइलीजथल) पीपरीडीन -4-यल] ग्राम एजसटामाइड 238 साइक् लगपरगफेंटनाइल एन-फेनाइल- एन -[1-(2-फेनाइल) 0.005 0.1 ZZO पीपरीडीन-4-यल] साइक् लगपरगपेन ग्राम ग्राम”. कॉरबगएक् साजमड [फा. सं. एन-13/1/2019-एनसी. II] ददनेि बौध्द, जनदेिक रटप्प णी: प्रधान अजधसूचना जिसे का.आ.1055 (अ , ददनांक 19 अक् टूबर, 2001 के तहत भारत के रािप्, असाधारण, भाग ।।, खण्ड 3, उपखण् ड (ii में प्रकाजि त दकया गया था और इसमें बाद में का.आ.2941 (अ , ददनांक 18 नि बर, 2009, का.आ.1430 (अ , ददनांक 21 िून, 2011, का.आ.375 (अ ददनांक 5 फरिरी, 2015, का.आ. 2375(अ , ददनांक 12 िपलाई, 2016, का.आ.384 (अ , ददनांक 2 मई, 2017, का.आ. 822(अ , ददनांक 27 फरिरी, 2018, का.आ.1762(अ , ददनांक 26 अप्रैल, 2018, का.आ.1351(अ , ददनांक13 माच,च 2019 के अंतगचत संिगधन दकया गया ह।ै NOTIFICATION New Delhi, the 23rd March, 2021 S.O. 1276(E).—In exercise of the powers conferred by clauses (viia) and (xxiiia) of section 2 of the Narcotic Drugs and Psychotropic Substances Act, 1985 (61 of 1985), the Central Government hereby makes the following further amendments in the notification of the Government of India, Ministry of Finance, Department of Revenue, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii) vide number S.O. 1055 (E), dated the 19th October, 2001, namely: - In the said notification, in the Table, after serial number 238 ZI, 238 ZJ, 238 ZK, 238 ZL, 238 ZM, 238 ZN, 238 ZO, 238 ZP, 238ZQ, 238ZR, 238ZS and 238 ZT and the entries relating thereto, the following serial numbers and entries shall be substituted, namely: - SI. No. Name of Narcotic Other Chemical name Small Commercial Drug and non- Quantity Quantity Psychotropic proprietary (in gm.) (in gm./kg.) Substance names (International non- proprietary name (INN)) “238ZI Carfentanil Methyl 1-(2-pheny lethyl)- 0.00005 gm 0.001 gm; 4- [phenyl(propnoyl)amino]pip eridine-4-carboxylate 238 ZJ Ocfentanil N-(2-Fluorophenyl)-2- 0.00217 gm 0.0434 gm; methoxy-N-[1-(2- phenylethyl)piperidin-4- l]acetamide 238 ZK Furanylfentanyl N-Phenyl-N-[1-(2- 0.02 gm 1 gm; phenylethyl)piperidin-4- y1]furan-2-carboxamide 238 ZL Acryloylfentanyl Acrrylfentan-yl N-Phenyl-N-[1-(2- 0.0025 gm 0.125 gm; phenylethyl)piperidin-4- y1]prop-2-enamide[भाग II—खण् ड 3(ii)] भारत का रािप् : असाधारण 9 238ZM 4- 4-FIBF, pFIBF N-(4-Fluoropheny)-2- 0.03 gm 1.5 gm; Fluoroisobutyrfentanyl methyl-N-[1-(2- phenylethyl)piperidin-4- yl]propenamide; 238 ZN Tetrahydrofuranylfenta THF N-Phenyl-N-[1-(2- 0.005 gm 0.1 gm; nyl phenylethy)piperidin-4- yl]oxolane-2-carboxamide 238 ZO AB- N-[(2S)-1-Amino-3-methyl- 0.05 gm 2.5 gm; CHMINACA 1-oxobutan-2-yl]-1- (cyclohexylmethyl)-1H- indazole-3-carboxamide 238 ZP 5F-ADB (5F- Methyl(2S)-2-{1-(5- 0.005 gm 0.25 gm; MDMB- fluorophentyl)-1H-indazole- PINACA) 3-carbonylamino}-3,3- dimethylbutanoate 238 ZQ AB-PINACA N-[(2S)-1-Amino-3-methyl- 0.0178 gm 0.892 gm; 1oxobutan-2yl]-1-penty1H- indazole 3-carboxamide 238 ZR UR-144 (1-Penty-1 H-indol-3- yl) 0.05 gm 2.5 gm; (2,2,3,3- tetramrthylcyclopropyl)met hanone 238 ZS 5F-PB-22 Quinolin-8-yl 1-(5- 0.1 gm 5.0 gm; fluropenthl)-1h-inodole-3- carboxylate 238 ZT 4-Fluoroamphetamine 4-FA 1-(4-Fluorophenyl) propan- 2 gm 50 gm; 2-amine 238ZU AB- N-[(2S)-1-amino-3-methyl- 0.025 gm 1.25 gm; FUBINACA 1-oxobutan-2-yl]-1- [(4- fluorophenyl) methyl] indazole-3- carboxamide 238ZV 5F-AMB- Methyl 2-({[1-(5- 0.0027 gm 0.135 gm; PINACA (5F- fluoropentyl)-1H- AMB, 5F- indazol3yl] carbonyl} MMB- amino)-3-methylbutanoate PINACA) 238ZW 5F-MDMB- Methyl(S)-2-(1-(5- 0.0050 gm 0.25 gm; PICA (5F- fluoropentyl)-1H-indole-3- MDMB-2201) carboxamido)-3,3- dimethylbutanoate 238ZX 4F-MDMB- Methyl(S)-2-(1-(4- 0.0050 gm 0.25 gm; BINACA fluorobutyl)-1H-indazole-3- carboxamido)-3,3- dimethylbutanoate 238ZY 4-CMC (4- clephedrone 1-(4-chlorophenyl)-2- 5.0 gm 250 gm; chloromethcathinone) (methylamino)-1- propanone 238ZZ N- 2-(Ethylamino)-1-phenyl-1- 1.0 gm 50 gm; ethylhexedrone hexanone 238ZZA alpha-PHP (RS)-1-Phenyl-2- 0.1 gm 5.0 gm; (pyrrolidine-1-yl)hexan-1- one10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 238ZZB flualprazolam 8-Chloro-6-(2-fluoro- 0.0125 gm 0.625 gm; phenyl)-1-methyl- 4hbenzo[f][1,2,4]triazolo[4, 3-a][1,4]diazepime 238ZZC Etizolam 4-(2-Chlorophenyl)-2-ethyl- 0.05 gm 2.5 gm; 9-methyl-6H-thieno[3,2- f][1,2,4]triazolo[4,3a][1,4]di azepine 238ZZD DOC 4-Chloro-2,5- 0.15 gm 7.5 gm; dimethoxyamfetamine 238ZZE ADB- N-[(2S)-1-amino-3,3- 0.01 gm 0.5 gm; FUBINACA dimethyl-1-oxobutan-2- yl]- 1-[(4-fluorophenyl)methyl]- 1Hindazole-3-carboxamide 238ZZF FUB-AMB, Methyl(2S)-2-({1-[4- 0.01 gm 0.5 gm; MMBFUBINA fluorophenyl]methyl- CA, 1Hindazole-3-carbonyl AMBFUBINA }amino)-3- methylbutanoate CA 238ZZG CUMYL- 1-(4-cyanobutyl)-N-(2- 0.01 gm 0.5 gm; 4CNBINACA phenylpropan-2-yl)- 1Hindazole-3-carboxamide 238ZZH ADB- N-[(2S)-1-amino-3,3- 0.005 gm 0.25 gm; CHMINACA, dimethyl-1-oxobutan-2- yl]- MAB- 1-(cyclohexylmethyl)-1H- CHMINACA indazole-3- carboxamide 238ZZI N- 1-(2H-1,3-benzodioxol-5- 0.1 gm 5 gm; ethylnorpentylo yl)-2- (ethylamino)pentan- ne 1-one 238 Crotonylfentanyl (2E)-N-phenyl-N-[1-(2- 0.014 gm 0.28 gm; ZZJ phenylethyl)piperidin-4- yl]but-2-enamide 238 Valerylfentanyl N-phenyl-N-[1-(2- 0.40 gm 8.0 gm; ZZK phenylethyl)piperidin-4- yl]pentanamide 238 Parafluorobutyrylfentanyl N-(4-fluorophenyl)-N-[1-(2- 0.005 gm 0.1 gm; ZZL phenylethyl) piperidin-4-yl] butanamide 238 Ortho-Fluorofentanyl N-(2-fluorophenyl)-N-[1-(2- 0.005 gm 0.1 gm; ZZM phenylethyl) piperidin-4-yl] propanamide 238 Methoxyacetyl fentanyl 2-methoxy-N-phenyl-N-[1- 0.005 gm 0.1 gm; ZZN (2-phenylethyl) piperidin-4- yl] acetamide 238 Cyclopropylfentanyl N-Phenyl-N-[1-(2- 0.005 gm 0.1 gm”. ZZO phenylethyl) piperidin-4-yl] cyclopropane carboxamide [F. No. N-13/1/2019-NC. II] DINESH BOUDDH, Director[भाग II—खण् ड 3(ii)] भारत का रािप् : असाधारण 11 Note : The principal notification was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), vide number S.O. 1055 (E), dated the 19th October, 2001 and subsequently amended vide numbers S.O. 2941 (E), dated the 18th November, 2009, S.O. 1430 (E), dated the 21st June, 2011, S.O. 375 (E) dated the 5th February, 2015, S. O. 2375(E), dated the 12th July, 2016, S.O. 384 (E), dated the 2nd May, 2017, S.O. 822(E), dated the 27th February, 2018, S.O. 1762(E), dated the 26th April, 2018 and S.O. 1351(E), dated the 13th March, 2019 Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Finance